FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783173081> ?p ?o ?g. }

• W2783173081 endingPage "42" @default.
• W2783173081 startingPage "34" @default.
• W2783173081 abstract "The number of ovarian cancer cases is predicted to rise by 14% in Europe and 55% worldwide over the next 2 decades. The current absence of a screening program, rising drug/treatment costs, and only marginal improvements in survival seen over the past 30 years suggest the need for maximizing primary surgical prevention to reduce the burden of ovarian cancer. Primary surgical prevention through risk-reducing salpingo-oophorectomy (RRSO) is well established as the most effective method for preventing ovarian cancer. In the UK, it has traditionally been offered to high-risk women (>10% lifetime risk of ovarian cancer) who have completed their family. The cost-effectiveness of RRSO in BRCA1/BRCA2 carriers older than 35 years is well established. Recently, RRSO has been shown to be cost-effective in postmenopausal women at lifetime ovarian cancer risks of 5% or greater and in premenopausal women at lifetime risks greater than 4%. The acceptability, uptake, and satisfaction with RRSO at these intermediate-risk levels remain to be established. Prospective outcome data on risk-reducing salpingectomy and delayed-oophorectomy for preventing ovarian cancer is lacking, and hence, this is best offered for primary prevention within the context and safe environment of a clinical trial. An estimated 63% of ovarian cancers occur in women with greater than 4% lifetime risk and 53% in those with 5% or greater lifetime-risk. Risk-reducing salpingo-oophorectomy can be offered for primary surgical prevention to women at intermediate risk levels (4%-5% to 10%). This includes unaffected women who have completed their family and have RAD51C, RAD51D, or BRIP1 gene mutations; first-degree relatives of women with invasive epithelial ovarian cancer; BRCA mutation-negative women from high-risk breast-and-ovarian cancer or ovarian-cancer-only families. In those with BRCA1, RAD51C/RAD51D/MMR mutations and the occasional families with a history of ovarian cancer in their 40s, surgery needs to be considered at younger than 45. In other moderate-risk gene mutation carriers and those with polygenic risk, RRSO needs be considered at 50. There is need for establishment/expansion of well-defined pathways to increase clinical access to RRSO. It is time to lower the risk threshold for RRSO to enable introduction of a targeted primary prevention approach, which could significantly impact the future burden of ovarian cancer." @default.
• W2783173081 created "2018-01-26" @default.
• W2783173081 creator A5027945638 @default.
• W2783173081 creator A5081082018 @default.
• W2783173081 date "2018-01-01" @default.
• W2783173081 modified "2023-10-18" @default.
• W2783173081 title "Setting the Threshold for Surgical Prevention in Women at Increased Risk of Ovarian Cancer" @default.
• W2783173081 cites W1540615297 @default.
• W2783173081 cites W1577886831 @default.
• W2783173081 cites W171490347 @default.
• W2783173081 cites W1871999639 @default.
• W2783173081 cites W1949412677 @default.
• W2783173081 cites W1967369103 @default.
• W2783173081 cites W1994948218 @default.
• W2783173081 cites W2014050356 @default.
• W2783173081 cites W2015837292 @default.
• W2783173081 cites W2045438979 @default.
• W2783173081 cites W2047041699 @default.
• W2783173081 cites W2064516418 @default.
• W2783173081 cites W2086199722 @default.
• W2783173081 cites W2094609745 @default.
• W2783173081 cites W2095936660 @default.
• W2783173081 cites W2100802093 @default.
• W2783173081 cites W2102089766 @default.
• W2783173081 cites W2102134278 @default.
• W2783173081 cites W2106568647 @default.
• W2783173081 cites W2108744675 @default.
• W2783173081 cites W2108873448 @default.
• W2783173081 cites W2110137106 @default.
• W2783173081 cites W2111012335 @default.
• W2783173081 cites W2114428497 @default.
• W2783173081 cites W2116799256 @default.
• W2783173081 cites W2117576401 @default.
• W2783173081 cites W2128601571 @default.
• W2783173081 cites W2132266605 @default.
• W2783173081 cites W2135195813 @default.
• W2783173081 cites W2137113327 @default.
• W2783173081 cites W2139557430 @default.
• W2783173081 cites W2140952719 @default.
• W2783173081 cites W2143924924 @default.
• W2783173081 cites W2149994587 @default.
• W2783173081 cites W2159077599 @default.
• W2783173081 cites W2168615516 @default.
• W2783173081 cites W2214802907 @default.
• W2783173081 cites W2404782822 @default.
• W2783173081 cites W2527779568 @default.
• W2783173081 cites W2528092098 @default.
• W2783173081 cites W2572326611 @default.
• W2783173081 cites W2586202612 @default.
• W2783173081 cites W2594216872 @default.
• W2783173081 cites W2601822003 @default.
• W2783173081 cites W2622582407 @default.
• W2783173081 cites W2627871710 @default.
• W2783173081 cites W2916179744 @default.
• W2783173081 doi "https://doi.org/10.1097/igc.0000000000001147" @default.
• W2783173081 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29252925" @default.
• W2783173081 hasPublicationYear "2018" @default.
• W2783173081 type Work @default.
• W2783173081 sameAs 2783173081 @default.
• W2783173081 citedByCount "21" @default.
• W2783173081 countsByYear W27831730812018 @default.
• W2783173081 countsByYear W27831730812019 @default.
• W2783173081 countsByYear W27831730812020 @default.
• W2783173081 countsByYear W27831730812021 @default.
• W2783173081 countsByYear W27831730812022 @default.
• W2783173081 countsByYear W27831730812023 @default.
• W2783173081 crossrefType "journal-article" @default.
• W2783173081 hasAuthorship W2783173081A5027945638 @default.
• W2783173081 hasAuthorship W2783173081A5081082018 @default.
• W2783173081 hasBestOaLocation W27831730812 @default.
• W2783173081 hasConcept C121608353 @default.
• W2783173081 hasConcept C126322002 @default.
• W2783173081 hasConcept C131872663 @default.
• W2783173081 hasConcept C141071460 @default.
• W2783173081 hasConcept C151730666 @default.
• W2783173081 hasConcept C2776018949 @default.
• W2783173081 hasConcept C2777696064 @default.
• W2783173081 hasConcept C2779234561 @default.
• W2783173081 hasConcept C2779343474 @default.
• W2783173081 hasConcept C2779494336 @default.
• W2783173081 hasConcept C2780164438 @default.
• W2783173081 hasConcept C2780427987 @default.
• W2783173081 hasConcept C29456083 @default.
• W2783173081 hasConcept C54355233 @default.
• W2783173081 hasConcept C71924100 @default.
• W2783173081 hasConcept C86803240 @default.
• W2783173081 hasConceptScore W2783173081C121608353 @default.
• W2783173081 hasConceptScore W2783173081C126322002 @default.
• W2783173081 hasConceptScore W2783173081C131872663 @default.
• W2783173081 hasConceptScore W2783173081C141071460 @default.
• W2783173081 hasConceptScore W2783173081C151730666 @default.
• W2783173081 hasConceptScore W2783173081C2776018949 @default.
• W2783173081 hasConceptScore W2783173081C2777696064 @default.
• W2783173081 hasConceptScore W2783173081C2779234561 @default.
• W2783173081 hasConceptScore W2783173081C2779343474 @default.
• W2783173081 hasConceptScore W2783173081C2779494336 @default.
• W2783173081 hasConceptScore W2783173081C2780164438 @default.
• W2783173081 hasConceptScore W2783173081C2780427987 @default.

• next